Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
24
pubmed:dateCreated
1991-1-29
pubmed:abstractText
6-(p-Hydroxyphenylhydrazino)uracil (H2-HPUra) is a selective and potent inhibitor of the replication-specific class III DNA polymerase (pol III) of Gr+ bacteria. Although formally a pyrimidine, H2-HPUra derives its inhibitory activity from its specific capacity to mimic the purine nucleotide, dGTP. We describe the successful conversion of the H2-HPUra inhibitor prototype to a bona fide purine, using N2-(benzyl)guanine (BG) as the basis. Structure-activity relationships of BGs carrying a variety of substituents on the aryl ring identified N2-(3,4-dichlorobenzyl)guanine (DCBG) as a nucleus equivalent to H2-HPUra with respect to potency and inhibitor mechanism. DCBdGTP, the 2'-deoxyribonucleoside 5'-triphosphate form of DCBG, was synthesized and characterized with respect to its action on wild-type and mutant forms of B. subtilis DNA pol III. DCBdGTP acted on pol III by the characteristic inhibitor mechanism and formally occupied the dNTP binding site with a fit which permitted its polymerization.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-101768, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-108667, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-143235, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-24361, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-2444869, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-2499883, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-2515995, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-3091344, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-3806587, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-411934, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-4473549, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-4628969, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-4630611, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-4633528, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-4957971, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-4992015, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-6694166, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-803493, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-815256, http://linkedlifedata.com/resource/pubmed/commentcorrection/2259629-816386
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0305-1048
pubmed:author
pubmed:issnType
Print
pubmed:day
25
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7381-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
Development of novel inhibitor probes of DNA polymerase III based on dGTP analogs of the HPUra type: base, nucleoside and nucleotide derivatives of N2-(3,4-dichlorobenzyl)guanine.
pubmed:affiliation
Department of Pharmacology, University of Massachusetts Medical School, Worcester 01655.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.